Global BioPharma Cold Chain Packaging Market Growth (Status and Outlook) 2023-2029

Global BioPharma Cold Chain Packaging Market Growth (Status and Outlook) 2023-2029

Packaging of products is the process of enclosing them for the purpose of their distribution, storage, sale, and use. Packaging also helps advertise a product in a better way and protect it from damage during transportation. Biopharma products are called as biological medical products, such as blood or blood components, vaccines, and tissues. These products require packaging to ensure their safety during transportation, to maintain sterility, and to prevent breakage or spillage and contamination.

LPI (LP Information)' newest research report, the “BioPharma Cold Chain Packaging Industry Forecast” looks at past sales and reviews total world BioPharma Cold Chain Packaging sales in 2022, providing a comprehensive analysis by region and market sector of projected BioPharma Cold Chain Packaging sales for 2023 through 2029. With BioPharma Cold Chain Packaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BioPharma Cold Chain Packaging industry.

This Insight Report provides a comprehensive analysis of the global BioPharma Cold Chain Packaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BioPharma Cold Chain Packaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global BioPharma Cold Chain Packaging market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BioPharma Cold Chain Packaging and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BioPharma Cold Chain Packaging.

The global BioPharma Cold Chain Packaging market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

The need for efficient packaging and transportation solutions in the biopharmaceutical industry primarily drives this market. Strict government regulations for packaging of biopharma products is impacting the market positively. FDA regulations in the US mandate the use of high barrier packaging materials and sealants for several liquid drugs. These drugs require packaging that exhibit impermeability, and chemicals and heat resisting capabilities. Governments in developing countries such as China and India are continuously upgrading their industry standards for packaging to maintain quality, safety, and to reduce breakage/spillage and contamination. This trend is likely to boost the demand for advanced biopharma chain packaging materials and logistics services during the forecast period. North America is the largest market in terms of consumption of pharma packaging, accounting for a market share of about 30% in 2017. In 2017, APAC accounted for 22% of the global market and is estimated to be the fastest growing biopharma cold chain packaging market.

This report presents a comprehensive overview, market shares, and growth opportunities of BioPharma Cold Chain Packaging market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Metal Packaging
Glass Packaging

Segmentation by application
Blood Components
Vaccines
Tissues
Cells
Stem Cells
Infectious Substances

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Amcor
CCL
Clondalkin
Gerresheimer

Please note: The report will take approximately 2 business days to prepare and deliver.